Centers for Disease Control and Prevention (CDC). Vital signs: Current cigarette smoking among adults aged ≥ 18 years—United States, 2009. MMWR.2010;59:1135–1140.
2.
TrinidadDRPérez-StableEJEmerySL. Intermittent and light smoking across race/ethnic groups in the United States. Nicotine Tob Res.2009;11:203–210.
3.
Pérez-StableEJHerreraBJacobPIIIBenowitzNL. Nicotine metabolism and intake in black and white smokers. JAMA.1998;280:152–156.
4.
BenowitzNLPérez-StableEJHerreraBJacobPR. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst.2002;94:108–115.
5.
FujiedaMYamazakiHSaitoT. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis.2004 Dec; 25(12):2451–2458, Epub 2004 Aug 12.
6.
CaraballoRSPechacekTFRichterP. Racial and ethnic differences in serum cotinine levels of cigarette smokers: The third national health and nutrition examination survey, 1988-1991. JAMA.1998;280:135–139.
7.
Pérez-StableEJMarínBVMarínG. Apparent underreporting of cigarette consumption among Mexican American smokers. Am J Public Health.1990;80:1057–1061.
8.
BenowitzNLBernertJTCaraballoRS. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol.2009;169:236–248.
9.
Centers for Disease Control. Vital signs: Nonsmoker's exposure to secondhand smoke—United States, 1999–2008. MMWR.2010;59:1141–1146.
10.
HoMKMwenifumboJCAl KoudsiN. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clin Pharmacol Ther.2009;85:635–643.
11.
SchollRAPattersonFWileytoEP. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study. Pharmacol Biocem Behav.2009;29:6–11.
12.
PattersonF. Toward personalized therapy for smoking cessation: A randomized placebo-controlled trial of bupropion. Clin Pharmacol Ther.2008;84:320–325.
13.
RiesLAGEisnerMPKosaryCLSEER Cancer Statistics Review, 1975–2003.Bethesda, Md: National Cancer Institute; 2006.
14.
JemalASiegelRWardE. Cancer statistics. CA Cancer J Clin.2006;56:106–130.
15.
HoweHLWuXRiesLA. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer.2006;107:1711–1742.
16.
HaimanCAStramDOWilkensLR. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med.2006;354:333–342.
17.
ThorgeirssonTEGellerFSulemP. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature.2008;452:638–642.
18.
Le MarchandLDerbyKSMurphySE. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res.2008;68:9137–9140.
19.
SpitzMRAmosCIDongQ. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst.2008;100:1552–1556.
20.
AmosCIWuXBroderickP. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet.2008;40:616–622.
21.
SacconeNLWangJCBreslauN. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res.2009;69:6848–6856.
22.
WeissRBBakerTBCannonDS. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet.2008;4:e1000125.
23.
WeiJMaJZPayneTJ. Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers. Hum Genet.2010;127:691–698.
24.
DavidSPMezukBZandiPP. Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in black and white Americans. Nicotine Tob Res.2010;12:251–262.
25.
BurchardEGBorrellLNChoudhryS. Latino populations: A unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am J Public Health.2005;95:2161–2168.
26.
BorrellLN. Racial identity among Hispanics: Implications for health and well-being. Am J Public Health.2005;95:379–381.
27.
BurchardEGZivECoyleN. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med.2003;348:1170–1175.
